The concomitant release of androstenedione with Cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism-Reference-Cited by-同舟云学术

The concomitant release of androstenedione with Cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism

Published:1993-01 Issue:1 Volume:7 Page:33-41
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Genazzani A. D.,Petraglia F.,Pianazzi F.,Volpogni C.,Genazzani A. R.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513599309152477

Reference19 articles.

1. Polycystic ovarian disease: A challenge and controversy

2. Diagnostic Approach to the Hirsute Patient

3. EPISODIC PULSATILE SECRETION OF FSH, LH, PROLACTIN, OESTRADIOL, OESTRONE, AND LH CIRCADIAN VARIATIONS IN POLYCYSTIC OVARY SYNDROME

4. Specific concordance index defines the physiological lag between LH and progesterone in women during the midluteal phase of the menstrual cycle

5. Control of circadian and episodic variations of adrenal androgens secretion in man

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anovulatory Syndrome;ISGE Series;2024

2. Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index;Gynecological Endocrinology;2022-06-24

3. Thyroid, Adrenal, PRL Impairments and Ovarian Function;Endocrines;2021-07-27

4. The relevance of inositols treatment for PCOS before and during ART;EUR REV MED PHARMACO;2021

5. Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause;ISGE Series;2021